Dr. Gillett and Nurse Practitioner James O'Hara delve into the reasons why withholding the publication of studies can be detrimental. 00:00 Intro01:05 Undisclosed Human Study07:07 Rapamycin and Ketamine Combination15:50 Lifespan Impact: SIRT2 Transgenic Over-expression in Mice18:23 Collaborative FDA Letter Addressing Obesity21:36 Advocating for the Publication of Surprising Findings28:32 Insights from Dr. Gillett's Surgical Experience29:34 ConclusionStudies/References► https://clinicaltrials.gov/study/NCT03190785#publications► https://pubmed.ncbi.nlm.nih.gov/32092760/► https://onlinelibrary.wiley.com/doi/full/10.1111/acel.14027► https://acsess.onlinelibrary.wiley.com/doi/full/10.2134/ael2015.10.0007► https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/1471-0528.15370For High-quality labs:► https://gilletthealth.com/order-lab-panels/For information on the Gillett Health clinic, lab panels, and health coaching:► https://GillettHealth.comFollow Gillett Health for more content from James and Kyle► https://instagram.com/gilletthealth► https://www.tiktok.com/@gilletthealth► https://twitter.com/gilletthealth► https://www.facebook.com/gilletthealthFollow Kyle Gillett, MD► https://instagram.com/kylegillettmdFollow James O’Hara, NP► https://Instagram.com/jamesoharanpFor 10% off Gorilla Mind products including SIGMA: Use code “GH10”► https://gorillamind.com/For discounts on high-quality supplements►https://www.thorne.com/u/GillettHealth#podcast #study #discussion #science #gilletthealthAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy